A systematic approach for stability-indicating HPLC method optimization for Nilotinib bulk through design of experiments: Application towards characterization of base degradation products by mass spectrometry-Reference-Cited by-同舟云学术

A systematic approach for stability-indicating HPLC method optimization for Nilotinib bulk through design of experiments: Application towards characterization of base degradation products by mass spectrometry

Published:2021-07 Issue:4 Volume:79 Page:387-394
ISSN:0003-4509
Container-title:Annales Pharmaceutiques Françaises
language:en
Short-container-title:Annales Pharmaceutiques Françaises

Author:

Narenderan S.T.^ORCID,Babu B.,Srikanth J.,Meyyanathan S.N.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference28 articles.

1. a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia;Jarkowski;Pharmacotherapy,2008

2. Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy;Breccia;Acta Haematol,2007

3. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography;Davies;Leuk Res,2010

4. High-performance liquid chromatography with ultraviolet detection and protein precipitation as a way of quantitative determination of nilotinib with and without internal standard;Dziadosz;J Liq Chromatogr Rel Technol,2012

5. High-performance liquid chromatography with solidphase extraction for the quantitative determination of nilotinib in human plasma;Miura;Biomed Chromatogr,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of an Ion-Pair Reverse Phase High-Performance Liquid Chromatography Method for the Detection of Major Components and Related Substances in Diquafosol Sodium Eye Drops;ACS Omega;2024-01-25

2. A Concise Review on Analytical Methods for Determination of Nilotinib;Current Analytical Chemistry;2023-08

3. Trace level detection and quantification of genotoxic impurities 3‐amino‐4‐methylbenzoate, 3‐amino‐4‐methylbenzoic acid, and 3‐(4‐methyl‐1H‐imidazol‐1‐yl)‐5‐(trifluoromethyl) aniline in Nilotinib dihydrochloride active pharmaceutical ingredient using liquid chromatography‐tandem mass spectrometry;SEPARATION SCIENCE PLUS;2022-05-17